BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2013
View Archived Issues
New point-of-care diagnostic biosensors for the detection of pathogens
Read More
A new allelic variant linked to the IRF3 gene
Read More
Eventus Diagnostics gains CE mark for Octava Pink breast cancer test
Read More
Sanofi details active first quarter 2013
Read More
Wellspring Biosciences presents novel mutant-specific KRas inhibitors
Read More
Newcastle disease virus developed for the treatment of prostate cancer
Read More
Results updated from phase II expansion study of SGI-110
Read More
Astellas and Drais form new partnership to develop treatment candidate for nocturia
Read More
Transgenomic and Amgen collaborate on test kits for metastatic colorectal cancer
Read More
Bayer discontinues TRUST phase II/III trial amid safety concerns
Read More
Seattle Genetics and Spirogen disclose novel anticancer agents
Read More
ChemRar and Sanofi enter scouting agreement for venture investment in Russia and Asia
Read More
Ablynx begins preclinical development of ALX-0962 for severe allergic asthma
Read More
Aileron Therapeutics completes first trial of a stapled peptide
Read More
Organizations gain grant to research TB, HIV and malaria vaccines
Read More
Yale University discloses new HIV reverse transcriptase inhibitors
Read More
FDA grants fast track status to Cubist Pharmaceuticals' QIDP candidate
Read More
AbbVie prepares novel anticancer agents
Read More
Opsona Therapeutics begins phase II study of OPN-305
Read More
The Scripps Research Institute forms agreement with Janssen Pharmaceuticals
Read More
AstraZeneca divulges novel BACE1 inhibitors
Read More
Shire reports progress for the first quarter of 2013
Read More
Brazilian researchers prepare new agents for cancer
Read More
Novel EGFR inhibitors for cancer presented by Teligene
Read More
Agile Therapeutics presents phase III results for Twirla, a novel contraceptive patch
Read More
Multiple ascending dose study of candidate for Marburg virus infection begins
Read More
GAP study of immunoglobulin in Alzheimer's disease misses primary endpoints
Read More